人羊膜间充质干细胞旁分泌对成骨细胞的影响

摘要/Abstract

摘要： 目的　探究人羊膜间充质干细胞（human amniotic mesenchymal stem cells, hAMSCs）旁分泌对人成骨细胞生物活性的影响。方法　酶消化法提取原代hAMSCs，并检测细胞表面标记物表达。收取hAMSCs 24 h培养上清与新鲜培养液1∶1配比作为条件培养基（condition medium，hAMSC-CM），以新鲜培养液作为阴性对照，作用于人成骨样细胞系MG63，观察对细胞生物活性的影响。MTT法检测连续1~4 d 细胞增殖情况；Transwell小室测定细胞2.5 h迁移情况，苏木素-伊红染色后拍照计数；对硝基苯磷酸二钠（pNPP）法检测培养5 d后细胞内ALP表达。结果　hAMSCs呈典型的成纤维样细胞形态，细胞表面阳性表达CD29、CD105、CD49d、CD44；阴性表达CD34、CD45、CD31和HLADR。hAMSC-CM在第1~3天均可显著促进MG63增殖（P<0.05）；hAMSC-CM显著增强MG63迁移能力（P<0.05）；hAMSC-CM培养组细胞中ALP表达显著强于对照组（P<0.05）。结论　hAMSCs可通过CM介导的旁分泌作用增强成骨细胞生物活性。

关键词: 人羊膜间充质干细胞, 成骨细胞, 条件培养基, 旁分泌

Abstract: Objective　To investigate the effect of human amniotic mesenchymal stem cells(hAMSCs) on osteoblast by paracrine manner. Methods　Primary hAMSCs were extracted by enzymatic digestion, and surface antigen markers were identified. Culture supernatant of hAMSCs after 24 h was collected and mixed with fresh medium by 1∶1, and was defined as condition medium(hAMSC-CM), while fresh medium was set as negative control. Their effects on the activities of MG63 were then detected. Cell proliferation was detected by MTT continuously for 4 days. The migrated cell number was estimated and counted after hematoxylin eosin staining by means of transwell system 2.5 h later. Alkaline phosphatase activity was measured after 5 days with p-Nitrophenyl Phosphate Disodium(pNPP). Results　hAMSCs showed the shape of fibroblast. Surface antigen markers were positive for CD29, CD105, CD49d, CD44， while negative for CD34, CD45, CD31, HLADR. hAMSC-CM promoted MG63 proliferation significantly during the first 3 days(P<0.05). Migration ability in hAMSC-CM group was enhanced prominently(P<0.05). ALP activity in cells cultured with hAMSC-CM exceeded control group markedly(P<0.05). Conclusion　hAMSCs are able to enhance the biological activity of osteoblast through CM mediated paracrine.

Key words: human amniotic mesenchymal stem cells, osteoblast, condition medium, paracrine

中图分类号:

R329.28

王贵玲洪滔淦岷仇丽鸿. 人羊膜间充质干细胞旁分泌对成骨细胞的影响[J]. 口腔医学, 2021, 41(1): 23-26.

参考文献 21

[1]	Kikuta J, Ishii M.Bone imaging: osteoclast and osteoblast dynamics[J]. Methods Mol Biol, 2018, 1763: 1-9.
[2]	Peng J, Chen L, Peng K, et al.Bone marrow mesenchymal stem cells and endothelial progenitor cells Co-culture enhances large segment bone defect repair[J].J Biomed Nanotechnol, 2019, 15(4):742-755
[3]	Kong Y, Zhao Y, Li D, et al.Dual delivery of encapsulated BM-MSCs and BMP-2 improves osteogenic differentiation and new bone formation[J].J Biomed Mater Res A, 2019, 107(10):2282-2295
[4]	王贵玲, 仇丽鸿, 庞希宁.间充质干细胞的旁分泌作用及其在颅颌面骨再生治疗中的应用研究进展[J].中国实用口腔科杂志, 2016, 9(6):373-378
[5]	Ferreira JR, Teixeira GQ, Santos SG, et al.Mesenchymal stromal cell secretome: influencing therapeutic potential by cellular pre-conditioning[J]. Front Immunol, 2018, 9: 2837.
[6]	Schmelzer E, McKeel DT, Gerlach JC.Characterization of human mesenchymal stem cells from different tissues and their membrane encasement for prospective transplantation therapies[J]. Biomed Res Int, 2019, 2019: 6376271.
[7]	Brown C, McKee C, Bakshi S, et al.Mesenchymal stem cells: Cell therapy and regeneration potential[J].J Tissue Eng Regen Med, 2019, 13(9):1738-1755
[8]	Davis LA, Dienelt A, zur Nieden NI.Absorption-based assays for the analysis of osteogenic and chondrogenic yield[J]. Methods Mol Biol, 2011, 690: 255-272.
[9]	Friedenstein AJ, Gorskaja JF, Kulagina NN.Fibroblast precursors in normal and irradiated mouse hematopoietic organs[J].Exp Hematol, 1976, 4(5):267-274
[10]	Mohammed EEA, El-Zawahry M, Farrag ARH, et al.Osteogenic differentiation potential of human bone marrow and amniotic fluid-derived mesenchymal stem cells in vitro & in vivo[J].Open Access Maced J Med Sci, 2019, 7(4):507-515
[11]	Leyva-Leyva M, Barrera L, López-Camarillo C, et al.Characterization of mesenchymal stem cell subpopulations from human amniotic membrane with dissimilar osteoblastic potential[J].Stem Cells Dev, 2013, 22(8):1275-1287
[12]	Bulati M, Miceli V, Gallo A, et al.The immunomodulatory properties of the human amnion-derived mesenchymal stromal/stem cells are induced by INF-γ produced by activated lymphomonocytes and are mediated by cell-to-cell contact and soluble factors[J]. Front Immunol, 2020, 11: 54.
[13]	Ando Y, Matsubara K, Ishikawa J, et al.Stem cell-conditioned medium accelerates distraction osteogenesis through multiple regenerative mechanisms[J]. Bone, 2014, 61: 82-90.
[14]	An JH, Park H, Song JA, et al.Transplantation of human umbilical cord blood-derived mesenchymal stem cells or their conditioned medium prevents bone loss in ovariectomized nude mice[J].Tissue Eng Part A, 2013, 19(5-6):685-696
[15]	Maacha S, Sidahmed H, Jacob S, et al.Paracrine mechanisms of mesenchymal stromal cells in angiogenesis[J]. Stem Cells Int, 2020, 2020: 4356359.
[16]	Beer L, Mildner M, Ankersmit HJ.Cell secretome based drug substances in regenerative medicine: when regulatory affairs meet basic science[J].Ann Transl Med, 2017, 5(7):170-
[17]	Alcaraz MJ, Compa? A, Guillén MI.Extracellular vesicles from mesenchymal stem cells as novel treatments for musculoskeletal diseases[J].Cells, 2019, 9(1):E98-
[18]	Wang YL, Jiang F, Liang Y, et al.Human amnion-derived mesenchymal stem cells promote osteogenic differentiation in human bone marrow mesenchymal stem cells by influencing the ERK1/2 signaling pathway[J]. Stem Cells Int, 2016, 2016: 1-12.
[19]	Wang JJ, Miao J, Meng X, et al.Expression of long non?coding RNAs in human bone marrow mesenchymal stem cells co?cultured with human amnion?derived mesenchymal stem cells[J].Mol Med Rep, 2017, 16(5):6683-6689
[20]	Wang YL, Yin Y, Jiang F, et al.Human amnion mesenchymal stem cells promote proliferation and osteogenic differentiation in human bone marrow mesenchymal stem cells[J].J Mol Histol, 2015, 46(1):13-20
[21]	Bogatcheva NV, Coleman ME.Conditioned medium of mesenchymal stromal cells: a new class of therapeutics[J].Biochemistry Mosc, 2019, 84(11):1375-1389